Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HERMIONE-7: Abemaciclib + AIs in Advanced Breast Cancer
NCT04227327Phase 2Terminated
- Sponsor
- University of Milano-Bicocca
- Start
- Jan 2020
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abemaciclib in breast cancer, sponsored by University of Milano-Bicocca. Started Jan 2020; status: terminated.
02
Drugs
abemaciclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04227327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04227327.